<DOC>
	<DOCNO>NCT00128154</DOCNO>
	<brief_summary>The purpose study determine whether chromium supplement reduce symptom metabolic syndrome , collection symptom increase one 's risk develop heart disease , stroke , diabetes .</brief_summary>
	<brief_title>Chromium Picolinate Treatment Metabolic Syndrome</brief_title>
	<detailed_description>Metabolic syndrome serious condition may lead number life-threatening disease . A reduction symptoms metabolic syndrome could result decreased morbidity health care cost increase quality life . Chromium essential mineral use breakdown fat , protein , carbohydrate . The cholesterol-lowering blood sugar-stabilizing property chromium make supplement strong candidate reducing symptom metabolic syndrome . This study determine whether chromium supplement reduce symptom metabolic syndrome abdominally obese individual . Participants randomly assign receive either chromium supplement placebo daily 16 week . Participants study visit study start Months 2 4 . A follow-up visit occur 5 month end intervention period . Blood test , urine test , nail clipping use assess lipoprotein cholesterol , insulin response glucose , lean body mass , blood pressure , oxidative stress , chromium level participant .</detailed_description>
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Metabolic Syndrome X</mesh_term>
	<mesh_term>Insulin Resistance</mesh_term>
	<mesh_term>Metabolic Diseases</mesh_term>
	<mesh_term>Prediabetic State</mesh_term>
	<mesh_term>Picolinic acid</mesh_term>
	<mesh_term>Chromium</mesh_term>
	<criteria>Meet least two follow criterion diagnosis metabolic syndrome : 1 ) systolic blood pressure high 130 mmHg diastolic blood pressure high 85 mmHg untreated patient OR use one approve antihypertensive agent ; 2 ) fast glucose high 110 mg/dL ; 3 ) fast triglyceride higher 150 mg/dL ; 4 ) high density lipoprotein ( HDL ) less 40 mg/dL men le 50 mg/dL woman Abdominal obesity define waist circumference high 40 inch men 35 inch woman Type 1 2 diabetes mellitus Use antihyperglycemic insulin sensitize medication within 3 month prior study entry Uncontrolled hypertension Triglycerides high 800 mg/dL Low density lipoprotein ( LDL ) cholesterol high 190 mg/dL History renal insufficiency History liver disease abnormal liver function test ( high 3x upper limit normal ) History atherosclerotic cardiovascular disease History congestive heart failure Cancer within 5 year prior study entry . Participants history skin cancer exclude . Surgery within 30 day prior study entry Use niacin within 6 week prior study entry Use fibrates within 12 week prior study entry History alcohol drug abuse Participation investigational drug study within 6 week prior study entry Any major active rheumatologic , pulmonary , dermatologic disease , inflammatory condition Unstable medical psychological condition would interfere study Use chromiumcontaining dietary supplement within 3 month prior study entry Allergy sensitivity chromium , picolinic acid , chromium picolinate Use beta blocker , corticosteroid , androgen , anticoagulant , antiarrhythmic within 3 month prior study entry Use dietary supplement within 30 day prior study entry . Participants use multivitamin , calcium , vitamin D , ( nonniacin ) B vitamins exclude . Pregnancy breastfeed</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>August 2006</verification_date>
	<keyword>Chromium</keyword>
	<keyword>Chromium picolinate</keyword>
	<keyword>Blood Glucose</keyword>
	<keyword>Cholesterol</keyword>
	<keyword>Complementary Therapies</keyword>
</DOC>